Nagasaka, Yasuko http://orcid.org/0000-0002-6259-3388
Wepler, Martin
Thoonen, Robrecht
Sips, Patrick Y.
Allen, Kaitlin
Graw, Jan A.
Yao, Vincent
Burns, Sara M.
Muenster, Stefan
Brouckaert, Peter
Miller, Keith
Solt, Ken
Buys, Emmanuel S.
Ichinose, Fumito
Zapol, Warren M.
Funding for this research was provided by:
National Institutes of Health (R01-HL110378, NIH/NEI 1R01EY022746-01, NIH/NEI 10SDG2610313, R01-GM104948)
POI-NIGMS (58448)
BOF-GOA and Ghent University and VIB (Licensing sGCα1-/- mice to industry)
Institute for the promotion of Innovation by Science and Technology in Flanders (NA)
Deutsche Forschungsgemeinschaft (DFG WE 5471/2-1)
Deutsche Forschungsgemeinschaft (DFG GR 4446/1-1)
MGH has obtained patents on inhaled Nitric Oxide (NA)
Ikaria ((Royalties))
Linde Gas Therapeutics ((Royalties))
Article History
Received: 30 September 2016
Accepted: 31 May 2017
First Online: 14 June 2017